Anaemia in heart failure patients: the prevalence of haematinic deficiencies and the role of ACE inhibitors and aspirin doses as risk factors

BACKGROUND: Patients with heart failure often have comorbidities that alter the progression of heart failure and impact on prognosis. One such comorbidity is anaemia, and clinicians have started to appreciate the full gravity of its impact on heart failure patients. Yet, the extent of the problem is...

Descripción completa

Detalles Bibliográficos
Autor principal: Guirguis, Kyrillos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463405/
https://www.ncbi.nlm.nih.gov/pubmed/31015880
http://dx.doi.org/10.18549/PharmPract.2019.1.1406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463405/
https://www.ncbi.nlm.nih.gov/pubmed/31015880
http://dx.doi.org/10.18549/PharmPract.2019.1.1406

Ejemplares similares